GS
75
2
HD
57
2
KEY
46
3
CSX
60
3
HON
67
2
SLB
55
2
CAH
48
-5
XRAY
28
2
STZ
54
-3
ISRG
74
-2
CRM
67
2
URI
65
5
DNB
82
4
LB
63
22
USB
55
-6
ILMN
42
5
EFX
38
2
RSG
71
3
IPG
56
3
AIV
72
2
GS
75
2
HD
57
2
KEY
46
3
CSX
60
3
HON
67
2
SLB
55
2
CAH
48
-5
XRAY
28
2
STZ
54
-3
ISRG
74
-2
CRM
67
2
URI
65
5
DNB
82
4
LB
63
22
USB
55
-6
ILMN
42
5
EFX
38
2
RSG
71
3
IPG
56
3
AIV
72
2
Financhill
Back

SELLAS Life Sciences Group Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

SLS
SELLAS Life Sciences Group

Last Price:
1.17
Seasonality Move:
12%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

SELLAS Life Sciences Group Price Quote

$1.17

SELLAS Life Sciences Group Key Stats

Sell
47
SELLAS Life Sciences Group (SLS) is a Sell
Day range:
$1.16 - $1.23
52-week range:
$0.50 - $1.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.18%
Volume:
965.3K
Avg. volume:
801K
1-year change:
15.84%
Market cap:
$82.3M
Revenue:
$0
EPS:
$-0.69

How Much Does SELLAS Life Sciences Group Make?

Data Unavailable

Is SELLAS Life Sciences Group Growing As A Company?

Data Unavailable

SELLAS Life Sciences Group Stock Price Performance

What Is SELLAS Life Sciences Group 52-Week High & Low?

SELLAS Life Sciences Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SELLAS Life Sciences Group?

Is SELLAS Life Sciences Group Cash Flow Positive?

  • What Is SLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.1M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $50.1M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

SELLAS Life Sciences Group Return On Invested Capital

Data Unavailable

SELLAS Life Sciences Group Earnings Date & Stock Price

SELLAS Life Sciences Group Competitors

SELLAS Life Sciences Group Dividend Yield

SELLAS Life Sciences Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.06%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.83
Upside from Last Price: 398.58%

Major Shareholders

  • How many SLS shares are owned by institutional investors?
    8.3M SLS shares are owned by institutional investors
  • How many SLS shares are owned by insiders?
    2.4M SLS shares are owned by insiders